Evaluation of Drug Abuse Treatment: A Repeated Measures Design Assessing Methadone Maintenance

Evaluation Review

Volumn 12, Issue 5, 1988, Pages 547-570

  Hser, Yih Ing ^a   Anglin, M Douglas ^a   Chou, Chih Ping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973746974     PISSN: 0193841X     EISSN: 15523926     Source Type: Journal    
DOI: 10.1177/0193841X8801200505     Document Type: Article

References (21)

1. Anglin, M. D. (Forthcoming) “The efficacy of civil commitment in treating narcotics addiction.” J. of Drug Issues.
2. Anglin, M.D., M. W. Booth, T. M. Ryan, and Y. Hser (1988) “Ethnic differences in narcotics addiction, Part II: Chicano and Anglo addiction career patterns.” In press: Int. J. of the Addictions.
3. Anglin, M. D. and D. G. Fisher (1987) “Survival analysis in drug program evaluation, Part II. Partitioning treatment effects.” Int. J. of the Addictions 22, 4: 377-387.
4. Anglin, M.D., Y. Hser, and M. W. Booth (1987) “Sex differences in addict careers: treatment.” Amer. J. of Drug and Alcohol Abuse 13, 3: 253-280.
5. Anglin, M. D. and W. H. McGlothlin (1983) “Methadone maintenance in California: a decade' s experience,” in L. Brill and C. Winick (Eds.) The Yearbook of Substance Use and Abuse. New York: Human Sciences.
6. Anglin, M.D., W. H. McGlothlin, G. R. Speckart, and T. M. Ryan (1983) Shutting off Methadone: The Closure of the San Diego County Methadone Maintenance Program. Final report, NIDA Grant #DA02577. Los Angeles: University of California, Los Angeles.
7. Anglin, M.D., W. H. McGlothlin, G. R. Speckart, T. M. Ryan, and M. W. Booth (forthcoming) Consequences and costs of shutting off methadone. Addictive Behavior.
8. Ball, J.C., W. R. Lange, C. P. Myers, and S. R. Friedman (1988) “The effectiveness of methadone maintenance treatment in reducing intravenous drug use and needle sharing among heroin addicts at risk for AIDS.” (unpublished)
9. California Administrative Code (1973) Title 9, subchapter 6, article 17, paragraph 1210, March 15.
10. Dole, V. P. and M. E. Nyswander (1965) “A medical treatment of diacetylmorphine (heroin) addiction.” J. of the Amer. Medical Assn 193, 8: 646-650.
11. Dole, V. P. and M. E. Nyswander (1968) “The use of methadone for narcotic blockade.” British J. of the Addictions 63: 55-57.
12. Fisher, D. G. and M. D. Anglin (1987) “Survival analysis in drug program evaluation: Part I. Overall program effectiveness.” Int. J. of the Addictions 22, 2: 115-134.
13. Hartgen, C.A., S. M. Mitchell, and N. D. Washburne (1976) Dynamics of Treatment in Therapeutic Communities. Technical Report 13. Newark, NJ: Rutgers University.
14. McGlothlin, W. H. and M. D. Anglin (1981a) “Long-term follow-up of clients of high- and low-dose methadone programs.” Archives of General Psychiatry 38: 1055-1063.
15. McGlothlin, W.H., and M. D. Anglin ( 1981b) “Shutting off methadone: costs and benefits.” Archives of General Psychiatry 38: 885-892.
16. McGlothlin, W.H., M. D. Anglin, and B. D. Wilson (1977) An Evaluation of the California Civil Addict Program. NIDA Services Research Monograph Series, DHEW Publication No. (ADM) 78-558. Washington, DC: Government Printing Office.
17. Nurco, D.N., A. J. Bonito, M. Lerner, and M. B. Balter (1975) “Studying addicts over time: methodology and preliminary findings.” Amer. J. of Drug and Alcohol Abuse 2: 183-196.
18. SAS Institute (1985) SAS User' s Guide: Statistics Version (5th ed.). Cary, NC: SAS Institute.
19. Senay, E. C. (1985) “Methadone maintenance treatment.” Int. J. of Addictions 20: 803-821.
20. Simpson, D. D. (1979) “The relation of time spent in drug abuse treatment to posttreatment outcome.” Amer. J. of Psychiatry 136, 11: 1449-1453.
21. Simpson, D. D. and S. B. Sells (1982) Effectiveness of Treatment for Drug Abuse: An Overview of the DARP Research Program. IBR Report 82-1. Fort Worth, TX: Institute of Behavioral Research, Texas Christian University.